These results suggest that a lower expression level of CCR6 mRNA in NSCLC patients with a larger tumors size (T feature) may be a selected feature of cancer cells acquiring the ability to emigrate from peripheral mucosal sites where CCL20 is highly expressed. This evidence concerns the gene CCL20 and cancer.